Promising Robotics Stocks To Keep An Eye On – March 4th

Teradyne, Ouster, and PROCEPT BioRobotics are the three Robotics stocks to watch today, according to MarketBeat’s stock screener tool. Robotics stocks are shares of publicly traded companies whose core businesses involve the design, manufacture or deployment of robots and robotic systems, including related components, control software, sensors, and integration services. Investors use them to gain exposure to the broader automation and AI-driven productivity trend across industries, though the group spans hardware, software and service providers with differing growth profiles and sensitivity to capital expenditure cycles. These companies had the highest dollar trading volume of any Robotics stocks within the last several days.

Teradyne (TER)

Teradyne, Inc. designs, develops, manufactures, and sells automated test systems and robotics products worldwide. It operates through four segments; Semiconductor Test, System Test, Robotics, and Wireless Test. The Semiconductor Test segment offers products and services for wafer level and device package testing of semiconductor devices in automotive, industrial, communications, consumer, smartphones, cloud, computer and electronic game, and other applications.

Read Our Latest Research Report on TER

Ouster (OUST)

Ouster, Inc. provides lidar sensors for the automotive, industrial, robotics, and smart infrastructure industries in Americas, the Asia-Pacific, Europe, the Middle East, and Africa. Its products include high-resolution scanning and solid-state digital lidar sensors, analog lidar sensors, and software solutions.

Read Our Latest Research Report on OUST

PROCEPT BioRobotics (PRCT)

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH).

Read Our Latest Research Report on PRCT

Read More